ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

81 - 100 out of 1,009 results.

SCIESCOPUS
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentomic patterns for multi-cancer early detection.

Kim, SY[Kim, Su Yeon]; Jeong, S[Jeong, Seongmun]; Lee, W[Lee, Wookjae]; Jeon, Y[Jeon, Yujin]; Kim, YJ[Kim, Yong-Jin]; Park, S[Park, Seowoo]; Go, D[Go, Dayoung]; Lee, S[Lee, Sanghoo]; Woo, HG[Woo, Hyun Goo]; Yoon, JK[Yoon, Jung-Ki], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC)

Cabanillas, ME[Cabanillas, Maria E.]; Lin, JJ[Lin, Jessica Jiyeong]; Brose, MS[Brose, Marcia S.]; McDermott, RS[McDermott, Raymond S.]; Almubarak, M[Almubarak, Mohammed]; Bauman, JR[Bauman, Jessica R.]; Casanova, M[Casanova, Michela]; Kummar, S[Kummar, Shivaani]; Lee, SH[Lee, Se-Hoon]; Leyvraz, S[Leyvraz, Serge], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting: DOMENICA study (GINECO-EN105b/ENGOT-en13 study)

Joly, F[Joly, Florence]; Ray-Coquard, IL[Ray-Coquard, Isabelle Laure]; Rubio, MJ[Rubio, Maria Jesus]; Paoletti, X[Paoletti, Xavier]; Davis, AJ[Davis, Alison J.]; Hudson, E[Hudson, Emma]; Lorusso, D[Lorusso, Domenica]; Tognon, G[Tognon, Germana]; Hasler-Strub, U[Hasler-Strub, Ursula]; Choi, CH[Choi, Chel Hun], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Belzutifan plus lenvatinib for patients (pts) with advanced clear cell renal cell carcinoma (ccRCC) after progression on a PD-1/L1 and VEGF inhibitor: Preliminary results of arm B5 of the phase 1/2 KEYMAKER-U03B study.

Albiges, L[Albiges, Laurence]; Beckermann, K[Beckermann, Katy]; Miller, WH[Miller, Wilson H.]; Goh, JC[Goh, Jeffrey C.]; Gajate, P[Gajate, Pablo]; Harris, CA[Harris, Carole A.]; Suarez, C[Suarez, Cristina]; Peer, A[Peer, Avivit]; Park, SH[Park, Se Hoon]; Stadler, WM[Stadler, Walter Michael], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09)

Kim, SY[Kim, Sun Young]; Kim, JH[Kim, Jee Hyun]; Kim, TY[Kim, Tae-Yong]; Park, SR[Park, Sook Ryun]; Yoon, S[Yoon, Shinkyo]; Lee, S[Lee, Soohyeon]; Lee, SH[Lee, Se-Hoon]; Kim, TM[Kim, Tae Min]; Han, SW[Han, Sae-Won]; Yun, H[Yun, Hongseok], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study.

Kim, J[Kim, Jinyong]; Lee, KH[Lee, Kyung-Hun]; Park, YH[Park, Yeon Hee]; Lin, CH[Lin, Ching-Hung]; Lu, YS[Lu, Yen-Shen]; Ueno, T[Ueno, Takayuki]; Yap, YS[Yap, Yoon Sim]; Yeo, W[Yeo, Winnie]; Liu, Q[Liu, Qiang]; Leung, RCY[Leung, Roland Ching-Yu], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF(V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study.

Riely, GJ[Riely, Gregory J.]; Smit, EF[Smit, Egbert F.]; Ahn, MJ[Ahn, Myung-Ju]; Felip, E[Felip, Enriqueta]; Ramalingam, SS[Ramalingam, Suresh S.]; Tsao, AS[Tsao, Anne S.]; Johnson, ML[Johnson, Melissa Lynne]; Gelsomino, F[Gelsomino, Francesco]; Esper, RM[Esper, Raymond M.]; Nadal, E[Nadal, Ernest], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer

Lee, J[Lee, Jeeyun]; Shergill, A[Shergill, Ardaman]; Park, H[Park, Haeseong]; Lee, KW[Lee, Keun-Wook]; Arkenau, HT[Arkenau, Hendrik-Tobias]; Kang, YK[Kang, Yoon-Koo]; Olowokure, OO[Olowokure, Olugbenga Olanrele]; Kim, JG[Kim, Jong Gwang]; Oh, SY[Oh, Sung Yong]; Oh, DY[Oh, Do-Youn], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors

Borad, MJ[Borad, Mitesh J.]; Schram, AM[Schram, Alison M.]; Kim, RD[Kim, Richard D.]; Kamath, SD[Kamath, Suneel Deepak]; Sahai, V[Sahai, Vaibhav]; Dotan, E[Dotan, Efrat]; Kelley, RK[Kelley, Robin Kate]; Ponz-Sarvise, M[Ponz-Sarvise, Mariano]; Oh, DY[Oh, Do-Youn]; Yachnin, J[Yachnin, Jeffrey], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Overall survival (OS) by response to first-line (1L) induction treatment with atezolizumab (atezo) plus platinum/gemcitabine (plt/gem) vs placebo plus plt/gem in patients (pts) with metastatic urothelial carcinoma (mUC): Updated data from the IMvigor130 OS final analysis

Grande, E[Grande, Enrique]; Bamias, A[Bamias, Aristotelis]; Galsky, MD[Galsky, Matt D.]; Kikuchi, E[Kikuchi, Eiji]; Davis, ID[Davis, Ian D.]; Arranz, JA[Arranz, Jose A.]; Rezazadeh, A[Rezazadeh, Arash]; del Muro, XG[del Muro, Xavier Garcia]; Park, SH[Park, Se Hoon]; De Giorgi, U[De Giorgi, Ugo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Long-term quality of life and nutritional results of stomach-preserving surgery after sentinel node evaluation in patients with early gastric cancer: A multicenter, randomized phase 3 trial (SENORITA)

Eom, BW[Eom, Bang Wool]; Yoon, HM[Yoon, Hong Man]; Kim, YW[Kim, Young-Woo]; Min, JS[Min, Jae Seok]; An, JY[An, Ji Yeong]; Hur, H[Hur, Hoon]; Lee, YJ[Lee, Young Joon]; Cho, GS[Cho, Gyu Seok]; Park, YK[Park, Young-Kyu]; Jung, MR[Jung, Mi Ran], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Capivasertib (C) and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2-advanced breast cancer (ABC): Characterization and management of common adverse events (AEs) from the phase 3 CAPItello-291 trial

Rugo, HS[Rugo, Hope S.]; Oliveira, M[Oliveira, Mafalda]; Howell, SJ[Howell, Sacha Jon]; Dalenc, F[Dalenc, Florence]; Cortes, J[Cortes, Javier]; Gomez, HL[Gomez, Henry Leonidas]; Hu, XC[Hu, Xichun]; Iwata, H[Iwata, Hiroji]; Jhaveri, KL[Jhaveri, Komal L.]; Loibl, S[Loibl, Sibylle], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non-small-cell lung cancer.

Johnson, ML[Johnson, Melissa Lynne]; Henry, JT[Henry, Jason Timothy]; Spira, AI[Spira, Alexander I.]; Battiste, J[Battiste, James]; Alnahhas, I[Alnahhas, Iyad]; Ahluwalia, MS[Ahluwalia, Manmeet Singh]; Barve, MA[Barve, Minal A.]; Edenfield, WJ[Edenfield, William Jeffery]; Nam, DH[Nam, Do-Hyun]; Eathiraj, S[Eathiraj, Sudharshan], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase 1/2 study of a first-in-human immune-stimulating antibody conjugate (ISAC) BDC-1001 in patients with advanced HER2-expressing solid tumors

Li, BT[Li, Bob T.]; Pegram, MD[Pegram, Mark D.]; Lee, KW[Lee, Keun-Wook]; Sharma, M[Sharma, Manish]; Lee, J[Lee, Jeeyun]; Spira, AI[Spira, Alexander I.]; Hanna, GJ[Hanna, Glenn J.]; Kang, YK[Kang, Yoon-Koo]; Rasco, DW[Rasco, Drew W.]; Moore, KN[Moore, Kathleen N.], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Golidocitinib in treating refractory or relapsed peripheral T-cell lymphoma: Primary analysis of the multinational pivotal study results (JACKPOT8).

Cai, QQ[Cai, Qingqing]; Zhu, J[Zhu, Jun]; Song, YQ[Song, Yuqin]; Zhao, WL[Zhao, Weili]; Zhou, KS[Zhou, Keshu]; Wu, JQ[Wu, Jianqiu]; Zhang, HL[Zhang, Huilai]; Malpica, L[Malpica, Luis]; Ding, KY[Ding, Kaiyang]; Liu, Y[Liu, Yao], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04

Modi, S[Modi, Shanu]; Niikura, N[Niikura, Naoki]; Yamashita, T[Yamashita, Toshinari]; Jacot, W[Jacot, William]; Sohn, J[Sohn, Joohyuk]; Tokunaga, E[Tokunaga, Eriko]; Vidal, MJ[Vidal, Maria Jesus]; Park, YH[Park, Yeon Hee]; Lee, KS[Lee, Keun Seok]; Chae, Y[Chae, Yeesoo], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase 1a/b study of BR101801, a PI3K gamma delta and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies

Kim, BS[Kim, Bong-Seog]; Kim, SJ[Kim, Seok Jin]; Kim, TM[Kim, Tae Min]; Yoon, DH[Yoon, Dok Hyun]; Kim, JS[Kim, Jin Seok]; Lee, E[Lee, Eunyoung]; Lee, WS[Lee, Won-Sik]; Lee, JO[Lee, Jeong-Ok]; Yang, DH[Yang, Deok-Hwan]

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Randomized phase 3 study of tarlatamab, a DLL3-targeting bispecific T-cell engager (BiTE), compared to standard of care in patients with relapsed small cell lung cancer (DeLLphi-304).

Paz-Ares, LG[Paz-Ares, Luis G.]; Felip, E[Felip, Enriqueta]; Ahn, MJ[Ahn, Myung-Ju]; Blackhall, FH[Blackhall, Fiona Helen]; Borghaei, H[Borghaei, Hossein]; Cho, BC[Cho, Byoung Chul]; Johnson, ML[Johnson, Melissa Lynne]; Ramalingam, SS[Ramalingam, Suresh S.]; Reck, M[Reck, Martin]; Zhang, A[Zhang, Alicia], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer

Scagliotti, G.V.[Scagliotti, Giorgio Vittorio]; Parikh, P.[Parikh, Purvish]; von, Pawel J.[von Pawel, Joachim]; Biesma, B.[Biesma, Bonne]; Vansteenkiste, J.[Vansteenkiste, Johan]; Manegold, C.[Manegold, Christian]; Serwatowski, P.[Serwatowski, Piotr]; Gatzemeier, U.[Gatzemeier, Ulrich]; Digumarti, R.[Digumarti, Raghunadharao]; Zukin, M.[Zukin, Mauro], et al.

ArticleIssue Date2023CitationJournal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, no.14, pp.2458 - 2466PublisherNLM (Medline)
SCIESCOPUS
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trialopen access

Tempero, M.A.[Tempero, M.A.]; Pelzer, U.[Pelzer, U.]; O'Reilly, E.M.[O'Reilly, E.M.]; Winter, J.[Winter, J.]; Oh, D.-Y.[Oh, D.-Y.]; Li, C.-P.[Li, C.-P.]; Tortora, G.[Tortora, G.]; Chang, H.-M.[Chang, H.-M.]; Lopez, C.D.[Lopez, C.D.]; Bekaii-Saab, T.[Bekaii-Saab, T.], et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.11, pp.2007 - 2019PublisherLippincott Williams and Wilkins
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어